Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

April 17, 2017Ariela KatzThe international CanStem303C trial is evaluating the combination of napabucasin, the most advanced cancer stemness inhibitor in development, with FOLFIRI chemotherapy in pati

Novel Drug Targets Cancer Stem Cell Pathway in Metastatic CRC Trial

April 17, 2017Ariela KatzThe international CanStem303C trial is evaluating the combination of napabucasin, the most advanced cancer stemness inhibitor in development, with FOLFIRI chemotherapy in pati
Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

June 14, 2016Vaishalee Kenkre, MD, Walter Longo, MDPeiman Hematti, MDThis pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem

Novel T-Cell Engineering Strategy Aims to Reduce GVHD in Lymphoma Transplantations

June 14, 2016Vaishalee Kenkre, MD, Walter Longo, MDPeiman Hematti, MDThis pilot trial is the first of its type to investigate T cell receptor alpha/beta-depleted and CD19-depleted haploidentical stem
No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

August 7, 2015Colleen S. Delaney, MD, MSCThe perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.Colleen

No Need to Wait for the Perfect Match-Cord Blood Is Saving Time and Lives

August 7, 2015Colleen S. Delaney, MD, MSCThe perception that cord blood is an inferior source of stem cells is simply not accurate and may result in delays in lifesaving treatment for patients.Colleen
Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

December 11, 2011Ben LeachStudy finds that peripheral blood stem cell (PBSC) transplants increase the incidence of graft-versus-host disease (GVHD).A new study has found that peripheral blood stem cel

Peripheral Blood Stem Cell (PBSC) Transplants Increase the Incidence of Graft-Versus-Host Disease (GVHD)

December 11, 2011Ben LeachStudy finds that peripheral blood stem cell (PBSC) transplants increase the incidence of graft-versus-host disease (GVHD).A new study has found that peripheral blood stem cel
Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15, 2011Bonnie GillisWilliam I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allog

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15, 2011Bonnie GillisWilliam I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allog
First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

February 11, 2016Greg KenneltyKelly JohnsonManish A. Shah, MD, discusses the BRIGHTER trial, which is investigated BBI608 as a second-line treatment for patients with gastric and gastroesophageal junc

First-in-Class Drug Targets Stem Cells in Gastric Cancer Trial

February 11, 2016Greg KenneltyKelly JohnsonManish A. Shah, MD, discusses the BRIGHTER trial, which is investigated BBI608 as a second-line treatment for patients with gastric and gastroesophageal junc
Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

June 21, 2018Gina ColumbusMax Wicha, MD, shares insight on the intriguing research being conducted on breast cancer stem cells.Max Wicha, MD, associate professor of oncology and urology at Johns Hopki

Breast Cancer Stem Cell Research Burgeoning With Vaccines, Epigenetic Therapeutic Developments

June 21, 2018Gina ColumbusMax Wicha, MD, shares insight on the intriguing research being conducted on breast cancer stem cells.Max Wicha, MD, associate professor of oncology and urology at Johns Hopki
Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

December 12, 2012Beth Fand IncollingoAn interview with Jenny C. Chang, MB BChir, MD, who broke new ground in cancer research when she identified and patented a 493-gene signature for breast cancer.Pho

Gaining Ground: Personal Losses Help Drive Pioneer in Stem Cell Study

December 12, 2012Beth Fand IncollingoAn interview with Jenny C. Chang, MB BChir, MD, who broke new ground in cancer research when she identified and patented a 493-gene signature for breast cancer.Pho
Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

June 21, 2020Denise MyshkoNearly 5 years after its approval for patients with multiple myeloma, daratumumab is now available in a formulation that can be administered in a fraction of the time require

Subcutaneous Daratumumab Offers Convenience for Patients With Multiple Myeloma

June 21, 2020Denise MyshkoNearly 5 years after its approval for patients with multiple myeloma, daratumumab is now available in a formulation that can be administered in a fraction of the time require
Pembrolizumab Recommended for EU Approval in Hodgkin Lymphoma

Pembrolizumab Recommended for EU Approval in Hodgkin Lymphoma

March 24, 2017Jason M. BroderickThe EMA’s Committee for Medicinal Products for Human Use has recommended approval of pembrolizumab for the treatment of adult patients with relapsed or refractory class

Pembrolizumab Recommended for EU Approval in Hodgkin Lymphoma

March 24, 2017Jason M. BroderickThe EMA’s Committee for Medicinal Products for Human Use has recommended approval of pembrolizumab for the treatment of adult patients with relapsed or refractory class
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...